4.0
26. März 2009
Aktueller Mitarbeiter
Saint Louis, MO
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Resources of a large pharmaceutical company, growth opportunities, many projects to get involved with and learn
Kontras
Constant M&A activity, communication gaps due to size of the company